Regencell CBO reports 581,514-share holding
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
3
Rhea-AI Filing Summary
Regencell Bioscience Holdings Ltd Chief Business Officer Au Yat-Pui filed a Form 3 reporting beneficial ownership of 581,514 ordinary shares held directly. The filing is an ownership disclosure and does not report any new share purchases or sales.
Insider Trade Summary
Holdings reported, no transactions
Holdings
Insider
AU YAT-PUI
Role
Chief Business Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Holding | Ordinary shares, par value $0.00001 | -- | -- | -- |
Holdings:
Ordinary shares, par value $0.00001 — 581,514 shares (Direct)
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the Regencell Bioscience (RGC) Form 3 filing show?
The Form 3 shows that Chief Business Officer Au Yat-Pui beneficially owns 581,514 ordinary shares of Regencell Bioscience Holdings Ltd. It is an ownership disclosure and does not indicate any recent purchases or sales.
Does the Regencell (RGC) Form 3 indicate insider buying or selling?
No, the Form 3 does not indicate insider buying or selling. It reports a holding entry showing 581,514 ordinary shares owned directly by Au Yat-Pui, with no transaction code, trade date pricing, or share purchase or sale amounts disclosed.
What role does the reporting person hold at Regencell Bioscience (RGC)?
The reporting person, Au Yat-Pui, is identified as the Chief Business Officer of Regencell Bioscience Holdings Ltd. The Form 3 links this officer role to direct beneficial ownership of 581,514 ordinary shares in the company.
AI-generated analysis. How Rhea-AI works. Not financial advice.